A real ‐world pharmacovigilance study of FDA adverse event reporting system events for sildenafil
ConclusionsThese findings emphasize the importance of monitoring and understanding the potential risks associated with sildenafil. Further investigation is warranted to validate these associations and address previously unrecognized safety concerns.
Source: Andrology - Category: Urology & Nephrology Authors: Yan Wang,
Bin Zhao,
Haiyan Yang,
Zheng Wan Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer & Oncology | Databases & Libraries | Disability | Erectile Dysfunction | Haemophilia | Hemophilia | Hypertension | Melanoma | Men | Skin Cancer | Study | Urology & Nephrology | USA Health | Viagra